Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2014

Jul 15, 2014

30826_dirs_2014-07-15_f777c95f-8b4f-4f5c-b8bd-61cab04997f1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2014-07-14

Reporting Person: Snodgres Jon (CFO)